Evidence map›Paper›PMID 33836590›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors.

Valeska Helfinger, Florian Freiherr von Gall, Nina Henke, Michael M Kunze, Tobias Schmid, Flavia Rezende, Juliana Heidler, Ilka Wittig, Heinfried H Radeke, Viola Marschall and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Lipopeptides fromBiotech (Basel (Switzerland)) · 2026
    Article
  3. Review
  4. Article
  5. Cell-drug conjugates.Nature biomedical engineering · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Impact ofIranian journal of biotechnology · 2022
    Article
  10. Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).Journal of cancer research and clinical oncology · 2022
    Article
  11. Article
  12. Review
  13. NADPH Oxidases in Pain Processing.Antioxidants (Basel, Switzerland) · 2022
    Review
  14. Review
  15. Review
  16. Cancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Valeska HelfingerInstitute for Cardiovascular Physiology, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-7103-2144
Florian Freiherr von GallInstitute for Cardiovascular Physiology, Goethe University, 60590 Frankfurt am Main, Germany.
Nina HenkeInstitute for Biochemistry I/ Pathobiochemistry, Goethe University, 60590 Frankfurt am Main, Germany.
Michael M KunzeInstitute for Biochemistry I/ Pathobiochemistry, Goethe University, 60590 Frankfurt am Main, Germany.
Tobias SchmidInstitute for Biochemistry I/ Pathobiochemistry, Goethe University, 60590 Frankfurt am Main, Germany.
Flavia RezendeInstitute for Cardiovascular Physiology, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0001-7864-9131
Juliana HeidlerFunctional Proteomics, SFB 815 Core Unit, Goethe University, 60590 Frankfurt am Main, Germany.
Ilka WittigFunctional Proteomics, SFB 815 Core Unit, Goethe University, 60590 Frankfurt am Main, Germany.
Heinfried H RadekePharmazentrum Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-4499-2510
Viola MarschallInstitute for Experimental Cancer Research in Pediatrics, Goethe University, 60590 Frankfurt am Main, Germany.
Karen AndersonSignaling Department, The Babraham Institute, Cambridge CB22 3AT, United Kingdom.ORCID 0000-0002-7394-6660
Ajay M ShahCardiovascular Division, King's College London British Heart Foundation Centre, London WC2R 2LS, United Kingdom.
Simone FuldaInstitute for Experimental Cancer Research in Pediatrics, Goethe University, 60590 Frankfurt am Main, Germany.
Bernhard BrüneInstitute for Biochemistry I/ Pathobiochemistry, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0001-8237-2841
Ralf P BrandesInstitute for Cardiovascular Physiology, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-8035-0048
Katrin SchröderInstitute for Cardiovascular Physiology, Goethe University, 60590 Frankfurt am Main, Germany; schroeder@vrc.uni-frankfurt.de.ORCID 0000-0002-3099-526X
Goethe University Frankfurt · DEBabraham Institute · GBKing's College London · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/B/000C0415British Heart Foundation CH/1999001/11735
6 · The paper itself

Abstract

Reactive oxygen species (ROS) can cause cellular damage and promote cancer development. Besides such harmful consequences of overproduction of ROS, all cells utilize ROS for signaling purposes and stabilization of cell homeostasis. In particular, the latter is supported by the NADPH oxidase 4 (Nox4) that constitutively produces low amounts of H

Indexed as

AnimalsCarcinogensCell NucleusCytosolDNA DamageGenomic InstabilityMiceNADPH Oxidase 4NeoplasmsOxidation-ReductionPhosphorylationProtein BindingProtein Phosphatase 2Protein SubunitsProto-Oncogene Proteins c-aktReactive Oxygen SpeciesCarcinogensNADPH Oxidase 4Nox4 protein, mouseProtein Phosphatase 2Protein SubunitsProto-Oncogene Proteins c-aktReactive Oxygen SpeciesAKTgenomic instabilityNox4solid tumors

Identifiers

PMID33836590
PMCPMC7980388
OpenAlexW3135785000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.